Advisornet Financial’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$745K Buy
1,674
+201
+14% +$89.5K 0.05% 291
2025
Q1
$714K Buy
1,473
+117
+9% +$56.7K 0.05% 275
2024
Q4
$546K Buy
1,356
+16
+1% +$6.44K 0.05% 298
2024
Q3
$623K Buy
1,340
+72
+6% +$33.5K 0.05% 289
2024
Q2
$594K Buy
1,268
+82
+7% +$38.4K 0.05% 274
2024
Q1
$496K Buy
1,186
+53
+5% +$22.2K 0.05% 309
2023
Q4
$461K Buy
1,133
+9
+0.8% +$3.66K 0.04% 332
2023
Q3
$391K Sell
1,124
-34
-3% -$11.8K 0.04% 339
2023
Q2
$408K Sell
1,158
-31
-3% -$10.9K 0.03% 339
2023
Q1
$375K Sell
1,189
-12
-1% -$3.78K 0.03% 345
2022
Q4
$347K Buy
1,201
+48
+4% +$13.9K 0.03% 358
2022
Q3
$334K Buy
1,153
+58
+5% +$16.8K 0.03% 396
2022
Q2
$309K Buy
1,095
+22
+2% +$6.21K 0.03% 410
2022
Q1
$280K Buy
1,073
+7
+0.7% +$1.83K 0.02% 475
2021
Q4
$234K Buy
1,066
+113
+12% +$24.8K 0.01% 564
2021
Q3
$173K Sell
953
-495
-34% -$89.9K 0.01% 621
2021
Q2
$292K Buy
1,448
+78
+6% +$15.7K 0.02% 485
2021
Q1
$294K Buy
1,370
+8
+0.6% +$1.72K 0.02% 455
2020
Q4
$322K Sell
1,362
-4
-0.3% -$946 0.03% 413
2020
Q3
$372K Sell
1,366
-187
-12% -$50.9K 0.03% 381
2020
Q2
$451K Sell
1,553
-77
-5% -$22.4K 0.04% 357
2020
Q1
$388K Buy
1,630
+68
+4% +$16.2K 0.04% 358
2019
Q4
$342K Sell
1,562
-148
-9% -$32.4K 0.03% 399
2019
Q3
$290K Buy
1,710
+325
+23% +$55.1K 0.03% 430
2019
Q2
$254K Hold
1,385
0.03% 410
2019
Q1
$255K Buy
1,385
+27
+2% +$4.97K 0.03% 389
2018
Q4
$225K Sell
1,358
-32
-2% -$5.3K 0.03% 386
2018
Q3
$268K Sell
1,390
-164
-11% -$31.6K 0.03% 367
2018
Q2
$264K Buy
1,554
+205
+15% +$34.8K 0.04% 338
2018
Q1
$220K Hold
1,349
0.03% 376
2017
Q4
$202K Buy
+1,349
New +$202K 0.03% 350